Global Handheld Ultrasound Devices Market Size, Trend & Opportunity Analysis Report, by End Use (Hospitals, Primary Clinics), Application (Trauma, Urology), and Forecast, 2025-20355
Global Handheld Ultrasound Devices Market Size, Opportunity Analysis and Forecast, 2025-2035
Market Definition and Introduction
The Global Handheld Ultrasound Devices Market was valued at USD 316.9 million in 2024 and is anticipated to reach USD 589.20 million by 2035, expanding at a CAGR of 5.80% during the forecast period 2025-2035. Portable ultrasound units are seen to have practically redefined medical imaging from bulky machinery to portable point-of-care devices, thus facilitating clinicians in numerous clinical settings. Initially confined to high-cost imaging centres, ultrasound technology has now instilled itself firmly in frontline healthcare: emergency rooms, ambulances, and even primary clinics. This transformation has been spurred by a magnified movement towards mobility, decentralised diagnostics, and precision-driven treatment pathways, thus allowing caregivers to make quick decisions at the bedside.
As trauma care, emergency medicine, and critical interventions are increasingly in demand for rapid diagnostic clarity, handheld ultrasound is becoming more and more infused in care protocols. Hospitals have started using ultrasound to fasten triage, detect internal injuries, and guide interventional procedures, while primary clinics use them to open access for patients in under-resourced areas where advanced imaging is limited. This adoption fits broadly within global health initiatives that push for early diagnoses, resource optimisation, and patient-
centric care delivery.
Manufacturers are aligning investments in AI-based imaging enhancement, ergonomics, and wireless compatibility on the supply side to augment the usability of these devices. Increased penetration of handheld ultrasound within urology, obstetrics, cardiology, and trauma care reinforces the disruptive nature of portable imaging. Value-based care and remote monitoring in healthcare ensure that handheld ultrasound devices fulfil their journey from being an adjunctive tool to a front-line diagnostic instrument, disentangling workflows, and widening the reach for clinical expertise through decentralised spaces.
Recent Developments in the Industry
- In January 2024, GE HealthCare presented how advanced features of Vscan Air- enhance diagnostic abilities in trauma and emergency care by allowing doctors to conduct faster point-of-care assessments.
- In March 2024, Butterfly Network Inc. announced an AI-enhanced software upgrade for its handheld ultrasound platform that targets accuracy in urology and emergency imaging while reducing operator dependency.
- In July 2023, an alliance was formed between Philips and global health organisations aimed at deploying affordable handheld ultrasound devices across rural clinics in Sub-Saharan Africa, thereby fortifying maternal and trauma care.
- In February 2025, Fujifilm introduced SonoSite LX Lite, a lightweight handheld ultrasound system optimised for urological examinations, with faster imaging and wireless reporting features.
- In May 2024, Samsung Medison launched a handheld ultrasound solution supporting direct cloud connectivity, thereby facilitating the conduct of seamless teleconsultation and multidisciplinary collaboration in primary care.
Market Dynamics
Point-of-care ultrasound speeds up diagnosis in trauma and emergency medicine.
Surgeons manage the rising burden of road accidents, sports injuries, and emergency surgical cases, notwithstanding the imposition of rapid bedside imaging. Ultrasound systems weighing a few kilograms can detect internal bleeding, fractures, or organ damage in minutes, while drastically reducing the time to make a diagnosis and improve patient outcomes in a busy trauma-care unit.
Increasing usage in urology vastly enlarges applications for the handheld ultrasound device.
Urologists have turned to portable ultrasound devices for fast, convenient, and safe imaging as the prevalence of urinary tract problems,
calculus disorders in the kidney, and prostate problems increases. The versatility of handheld probes in bladder scanning and guided catheterisation procedures has made them indispensable in both outpatient and hospital settings, thereby strengthening their long-term adoption.
Technological innovations sustain demand amid reimbursement challenges.
Integrating AI for automated interpretation, machine learning for anomaly detection, and cloud-based data sharing has widely enhanced the devices' applications. Much lower adoption in developing economies, through reimbursement gaps, lack of trained personnel, and questions about image resolution as compared to high-end cart-based systems, are some barriers against these advancements.
With increased rural healthcare access comes an enormous opportunity for growth.
Governments and NGOs are funding mobile diagnostic devices to tackle inequality in the healthcare sector. Handheld ultrasound devices are being employed through rural clinics and mobile healthcare units. Its affordability, ease of use, and portability allow it to become a handy diagnostic tool in areas with a lack of frameworks works creating bright chances for manufacturers eyeing emerging markets.
Growth hampered by supply chain disruptions and regulatory compliance hurdles.
The shortages of semiconductors globally, interruptions in logistics incurred during the pandemic, and strict regulatory approvals for devices have sporadically delayed production and commercialisation. Consequently, players are forced to diversify their manufacturing bases, speed up regulatory clearances and build supply networks at the same time to sustain market momentum.
Attractive Opportunities in the Market
- AI-Powered Imaging Growth - Expanding role of artificial intelligence to improve diagnostic precision and reduce operator dependency.
- Rural Healthcare Expansion - Increasing deployment of handheld ultrasound in rural clinics to close diagnostic access gaps.
- Trauma Care Adoption - Rising global trauma cases fuel emergency room integration of portable imaging technologies.
- Urology Segment Upsurge - Non-invasive urological diagnostics enhance adoption across hospitals and primary clinics.
- Telehealth Integration Rising - Cloud-enabled ultrasound imaging enhances remote consultations and cross-disciplinary collaboration.
- Emerging Market Penetration - Substantial opportunities in Asia-Pacific and Africa as healthcare infrastructure expands.
- Ergonomic Device Innovations - Development of lightweight, durable probes enhances usability in high-volume care settings.
- Value-Based Care Support - Handheld devices align with cost-effective healthcare models focused on efficiency and outcomes.
- Training & Education Demand - Growing requirement for simulation-based training modules accelerates device adoption.
- Collaborative R&D Projects - Partnerships among device makers, hospitals, and tech firms drive customised imaging solutions.
Report Segmentation
By End Use: Hospitals, Primary Clinics
By Application: Trauma, Urology
By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)
Key Market Players: GE HealthCare, Butterfly Network Inc., Philips, Clarius Mobile Health, Fujifilm Holdings, Samsung Medison, Canon Medical Systems, Mindray, Siemens Healthineers, and Healcerion.
Report Aspects
Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2024-2035
Report Pages: 292
Dominating Segments
Between all the areas of diagnosis within their four walls, hospitals will be the primary place in which handheld ultrasound devices will be used during the next half-decade.
Emergency departments apply the point of care for trauma diagnostics, and surgery units use them for guided interventions. That versatility allows hospitals to maximise workflow and avoid being attached permanently to a cart, a high-end "conventional" ultrasound. All these factors make hospitals the most lucrative segment of such resource investments on account of the purchasing power.
Primary clinics rise as decentralised diagnostic access expands globally.
With the lowering of expenses and the availability of cheap handheld ultrasound devices, rural and semi-urban primary clinics are turning to investing in these to cover diagnostic gaps. Their affordability, portability, and ease of use in a non-specialist environment make them attractive to these physicians. The primary clinics have been acquiring them for initial assessments of trauma, bladder scans, and pregnancies, emphasising their contribution toward more affordable access to imaging. With these policies insisting on prevention and early diagnosis, this segment is going to develop rapidly.
Trauma applications spearhead handheld ultrasound utility in critical care.
Among the most significant areas of application for handheld ultrasound is trauma care. Portable devices have been crucial in performing FAST tests that guide emergency decisions concerning internal bleeding, fractures, or surgical interventions. With increased worldwide road traffic accidents and emergency cases, the focus of handheld ultrasound is expected to expand into trauma.
The urology segment shows steady growth with non-invasive diagnostic applications.
Handheld ultrasound devices are now indispensable in urology for bladder volume assessment, kidney imaging, and prostate monitoring. The preference for these devices has been owing to their noninvasiveness and the immediate provision of diagnostic insight. As more and more urological disorders develop, especially among the older population, this segment is expected to experience continuous growth as innovations in device development continue.
Key Takeaways
- Hospital Leadership - Hospitals remain dominant end-use owing to multidisciplinary integration and procurement capacity.
- Primary Care Growth - Expanding clinic adoption strengthens early diagnosis and decentralised imaging pathways.
- Trauma Segment Strength - Emergency care dependence on portable ultrasound ensures a strong growth trajectory.
- Urology Expansion - Increasing urological disease prevalence drives portable imaging adoption in speciality care.
- AI Innovation Surge - Image automation and machine learning integration elevate clinical efficiency.
- Emerging Market Opportunity - Asia-Pacific and Africa provide new growth frontiers for portable imaging.
- Telehealth Synergy - Cloud-enabled imaging aligns handheld ultrasound with digital healthcare ecosystems.
- Supply Chain Volatility - Semiconductor shortages and regulatory hurdles continue to restrain smooth expansion.
- Training Demand Increase - Clinical training programs accelerate adoption across hospitals and primary care.
- Collaborative Ecosystem Rise - Partnerships foster innovation in customised handheld ultrasound solutions.
Regional Insights
North America has a strong hospital infrastructure supportive of new technologies and innovations, making it the leader in the handheld ultrasound pack.
Because of the well-established hospital networks, high penetration of advanced diagnostic equipment, and aggressive integration of AI technologies, North America, spearheaded by the United States, is a really strong region for handheld ultrasound adoption. Continuous innovation is enforced by the presence of the dominant players in the region: GE HealthCare, Philips, and Butterfly Network. The region is further strengthened through regulatory incentives favouring point-of-care technologies.
Europe leads the handheld ultrasound adoption, mainly through eco-innovation and clinical integration.
In Europe, a strong emphasis on reducing the environmental impact of technologies and on modernising the health sector is consolidating the handheld ultrasound position. Germany, France, and the UK take precedence in promoting portable ultrasound installations in hospitals and primary care clinics, having secured government backing through funding proposals.
Asia-Pacific is set as the fastest-growing market for handheld ultrasound devices.
The uninterrupted growth of handheld ultrasound in this region is due to rapid expansions in health care facilities in China, India, and Southeast Asia. An abundance of opportunities arises with local governments' initiatives directing attention toward rural healthcare and the expansion of mobile medical services. Furthermore, cost-effective portable diagnostics are set on the path of sustained growth as the pharmaceutical and medical device industries in Asia invest in advancing them.
LAMEA reactivates handheld ultrasound adoption through general healthcare improvement.
There is moderate growth in handheld ultrasound adoption in Latin America, the Middle East, and Africa, with investment in government interest toward healthcare improvement. Imaging services in hospitals are being increased in Brazil and the UAE, while handheld ultrasound devices by NGOs and other aid programs are operational in rural clinics in Africa. Infrastructure gaps do restrain this growth, but increasing partnerships with global players is making it more accessible.
Key Benefits for Stakeholders
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.
Frequently Asked Question(FAQ) :
Hospitals are the dominating end-use segment. This leadership is attributed to their high procurement capacity, the integration of handheld devices into multidisciplinary workflows (such as emergency departments and surgical units), and the need for versatile point-of-care tools for rapid triage and guided interventions.
The two spearheading applications are Trauma and Urology. In trauma care, devices are used for rapid FAST tests to detect internal bleeding or organ damage. In urology, they are increasingly indispensable for non-invasive bladder volume assessments, kidney imaging, and prostate monitoring.
AI is being integrated to enhance diagnostic precision, provide automated interpretation, and reduce operator dependency. Recent developments include Butterfly Network’s AI-enhanced software for urology and emergency imaging, which helps clinicians make more accurate assessments regardless of their level of expertise.
Asia-Pacific is identified as the fastest-growing region. This growth is fueled by rapid healthcare infrastructure expansion in China, India, and Southeast Asia, alongside government initiatives focused on rural healthcare and mobile medical services.
Handheld ultrasound devices act as a bridge to close diagnostic access gaps in under-resourced areas. Due to their affordability and portability, they are being deployed by governments and NGOs in rural clinics and mobile units to provide essential imaging services where high-end cart-based systems are unavailable.
The industry is grappling with global semiconductor shortages, logistics interruptions, and strict regulatory compliance hurdles. These factors have sporadically delayed production and commercialization, forcing players to diversify manufacturing bases and accelerate regulatory clearance processes.
Cloud-enabled connectivity allows for seamless teleconsultation and multidisciplinary collaboration. For example, Samsung Medison’s recent launch supports direct cloud connectivity, enabling primary care providers to share images with specialists remotely, thereby improving patient-centric care.
North America leads due to its well-established hospital networks, high penetration of advanced diagnostic equipment, and strong presence of key industry players like GE HealthCare and Philips. Additionally, the region benefits from regulatory incentives that favor point-of-care technology integration.
Despite the benefits, adoption is hindered by reimbursement gaps, a lack of trained personnel to operate the devices, and concerns regarding image resolution when compared to traditional, high-end cart-based ultrasound systems.
